Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Financial Results

Every financial results filing by a US-listed company that our alert engine sent, newest first.

4:42 PM ET 8-K
Financial Results Laird Superfood, Inc. LSF

Laird Superfood Financial Results

Laird Superfood reported Q3 2026 financial results, featuring a 225% revenue increase to $42.0 million following the acquisitions of Navitas Organics and Terrasoul Superfoods. The company achieved profitability with net income of $1.7 million and Adjusted EBITDA of $2.1 million, driven by acquisition synergies and retail distribution expansion.

Term
Q3 2026

“Q3 was our first full quarter operating Laird Superfood, Navitas Organics, and Terrasoul Superfoods as one platform. Net sales grew 225% to $42.0 million, and Adjusted EBITDA reached $2.1 million as we began capturing synergies. We remain excited by the consumer opportunities in front of us and are increasing our marketing activity to capture and sustain growth from the health and wellness trends that continue to play into the strenghts of our brands. Our new executive team is now in place and, with $17.3 million in cash and no debt, we are well positioned for continued, profitable growth.”

Jason Vieth, Chief Executive Officer
4:42 PM ET 8-K
Financial Results Battalion Oil Corp BATL

Battalion Oil Financial Results

Battalion Oil Corporation reported third quarter 2026 financial results, generating sales volumes of 11,359 Boe/d and total operating revenue of $45.6 million. The company highlighted a significant balance sheet transformation, ending the quarter with $92.1 million in cash and reducing net debt to $70.4 million. Additionally, the company executed a transformative midstream transaction to shift crude transportation from trucking to pipeline, expected to significantly lower gathering costs.

Term
Q3 2026

“Our commitment to operational excellence has shown in our third quarter results. I’m proud of the team and look forward to continued execution”

Daniel Rohling, COO of Battalion
4:42 PM ET 10-Q
Financial Results American Battery Materials, Inc. BLTH

American Battery Materials Q3 2026 Results: Net Loss of $901K, Loss Narrows

American Battery Materials Inc. reported a net loss of $6.09 million for the nine months ended September 30, 2026, driven by significant non-cash expenses related to debt extinguishment and note modifications. The company faces substantial liquidity challenges with a working capital deficit of $13.3 million and only $1,465 in cash, leading to an expressed doubt about its ability to continue as a going concern.

Key figure
Net loss $901K
4:41 PM ET 10-Q
Financial Results Talphera, Inc. TLPH

Talphera Q3 2026 Results: Net Loss of $4.02M, Loss Narrows

For the nine months ended September 30, 2026, Talphera reported a net loss of $10.9 million, compared to a $10.5 million loss in the prior year period. Operating expenses increased to $12.0 million, driven by higher research and development costs related to the Niyad product candidate, while cash and short-term investments totaled $14.2 million.

Key figure
Net loss $4.02M
4:41 PM ET 8-K
Financial Results DiaMedica Therapeutics Inc. DMAC

DiaMedica Therapeutics Financial Results

DiaMedica Therapeutics reported Q3 2026 financial results and provided clinical updates on its DM199 programs. The company completed enrollment in the first two cohorts of its Phase 2 fetal growth restriction (FGR) trial and surpassed the 200-participant enrollment threshold for its ReMEDy2 Phase 2/3 acute ischemic stroke trial, with an interim analysis expected in Q1 2027.

Term
Q3 2026

“During the third quarter and recent weeks, we continued to advance DM199 across each of our clinical programs, including completing enrollment in the first two cohorts of our Phase 2 early-onset fetal growth restriction study and reaching the 200-participant enrollment threshold for the planned interim analysis of ReMEDy2.”

Rick Pauls, President and Chief Executive Officer

“Our clinical programs are providing important opportunities to evaluate the pharmacologic effects of DM199 across pregnancy-related vascular disorders and acute ischemic stroke.”

Julie Krop, MD, Chief Medical Officer
4:40 PM ET 10-Q
Financial Results CapsoVision, Inc CV

CapsoVision Q3 2026 Results: Net Loss of $7.34M, Loss Narrows

CapsoVision reported a net revenue of $10.0 million for the nine months ended September 30, 2026, a slight increase from $9.6 million in the prior year. However, the company experienced a net loss of $21.9 million during this period, driven by high research and development expenses as they pursue FDA clearances for new products like the CapsoCam Colon capsule and AI capabilities.

Key figure
Net loss $7.34M
4:39 PM ET 10-Q
Financial Results T1 Energy Inc. TE

T1 Energy Q3 2026 Results: Net Loss of $40.6M, Loss Narrows

T1 Energy Inc. reported a significant increase in total net sales to $624.4 million for the nine months ended September 30, 2026, driven largely by related party transactions. Despite the revenue growth, the company incurred a net loss of $104.5 million for the period, though this was an improvement from the $178.7 million loss in the prior year.

Key figure
Net loss $40.6M
4:39 PM ET 10-Q
Financial Results Blackstone Private Credit Fund BCRED

Blackstone Private Credit Fund Q3 2026 Results: Net Income $704M, Down 12.5% YoY

As of September 30, 2026, Blackstone Private Credit Fund reported total assets of $79.1 billion and total net assets of $41.1 billion, reflecting a decrease from $47.6 billion at year-end 2025. The fund's investment portfolio is primarily composed of non-controlled/non-affiliated investments valued at $71.3 billion, supported by $34.2 billion in debt.

Key figure
Net income $704M · -12.5% YoY
4:39 PM ET 8-K
Financial Results Dillard's, Inc. DDS

Dillard's Financial Results

Dillard's reported Q3 2026 net income of $130.9 million, or $8.38 per share, on total retail sales of $1.418 billion. The company achieved 1% comparable store sales growth and maintained a strong retail gross margin of 45.3%.

Term
Q3 2026

“We achieved 1% sales growth on top of last year’s 3% increase, supporting a strong 45.3% retail gross margin. As we head into the holidays, our stores and dedicated team are ready to welcome and serve our customers.”

William T. Dillard, II, Chief Executive Officer
4:39 PM ET 10-Q
Financial Results Nakamoto Inc. NAKA

Nakamoto Q3 2026 Results: Turns Profitable, Net Income $85.5M

Nakamoto Inc. reported a net income of $85.5 million for the quarter ended September 30, 2026, a significant recovery from an $86.0 million loss in the prior year, primarily driven by a $110.4 million gain on the fair value of digital assets. However, the company faces a year-to-date net loss of $286.2 million due to substantial goodwill impairment and non-operating expenses earlier in the year.

Key figure
Net income $85.5M
4:39 PM ET 10-Q
Financial Results NeuroPace Inc NPCE ▶ Call

NeuroPace Q3 2026 Results: Net Loss of $3.3M, Loss Narrows

NeuroPace reported a decrease in total assets from $105.6 million at the end of 2025 to $94.8 million as of September 30, 2026, primarily driven by a reduction in cash and short-term investments. The company maintains a significant accumulated deficit of $568.6 million and expects to lose its emerging growth company status on December 31, 2026.

Key figure
Net loss $3.3M
4:38 PM ET 10-Q
Financial Results Gaxos.Ai Inc. GXAI

Gaxos.Ai Q3 2026 Results: Net Loss of $930K, Loss Narrows

GAXOS.AI INC. reported a significant revenue increase to $7.08 million for the nine months ended September 30, 2026, compared to $0.69 million in the prior year, driven by a $1.75 million gain on the sale of gaming assets. Despite the revenue growth, the company incurred a net loss attributable to common shareholders of $2.86 million due to a substantial rise in selling, general, and administrative expenses.

Key figure
Net loss $930K
4:38 PM ET 10-Q
Financial Results Liquidmetal Technologies Inc LQMT

Liquidmetal Technologies Q3 2026 Results: Net Loss of $767K, Loss Widens

Liquidmetal Technologies reported a net loss of $2.37 million for the nine months ended September 30, 2026, compared to $1.64 million in the prior year period. While product revenue increased slightly to $674 thousand, the company faced higher operating expenses and a $220 thousand loss on the disposal of property and equipment.

Key figure
Net loss $767K
4:38 PM ET 10-Q
Financial Results American National Group Inc. ANG-PD

American National Group Q3 2026 Results: Net Income $945M, Up 331.5% YoY

American National Group Inc. reported net income attributable to common stockholders of $939 million for the third quarter of 2026, a significant increase from $208 million in the prior year period. Total assets remained stable at $130.5 billion, while total equity decreased to $8.1 billion primarily due to a $2.2 billion unrealized investment loss recorded in other comprehensive income.

Key figure
Net income $945M · +331.5% YoY
4:38 PM ET 10-Q
Financial Results Commonwealth Credit Partners BDC I, Inc.

Commonwealth Credit Partners BDC I Q3 2026 Results: Net Income $4.9M, Down 27.3% YoY

For the nine months ended September 30, 2026, Commonwealth Credit Partners BDC I, Inc. reported total investment income of $45.8 million and net investment income of $35.5 million, both down from the prior year period. Net asset value per share decreased to $866.13 from $895.75 at year-end 2025, primarily driven by $17.2 million in net unrealized losses on investments.

Key figure
Net income $4.9M · -27.3% YoY
4:37 PM ET 10-Q
Financial Results Bain Capital Private Credit

Bain Capital Private Credit Q3 2026 Results: Net Income $32.4M, Up 51.8% YoY

Bain Capital Private Credit reported total investment income of $173.3 million for the nine months ended September 30, 2026, a significant increase from $88.3 million in the prior year period. Net investment income grew to $83.1 million as the company expanded its investment portfolio to $2.4 billion at fair value, up from $1.68 billion at the end of 2025.

Key figure
Net income $32.4M · +51.8% YoY
4:36 PM ET 10-Q
Financial Results AIM ImmunoTech Inc. AIM

AIM ImmunoTech Q3 2026 Results: Net Loss of $3.14M, Loss Narrows

AIM ImmunoTech reported a net loss of $9.95 million for the nine months ended September 30, 2026, compared to $9.78 million in the prior year. The company significantly strengthened its balance sheet through equity offerings and warrant exercises, increasing total assets to $9.75 million and achieving a positive stockholders' equity of $7.08 million.

Key figure
Net loss $3.14M
4:36 PM ET 10-Q
Financial Results SES AI Corp SES

SES AI Q3 2026 Results: Net Loss of $13.4M, Loss Narrows

SES AI Corp reported total current assets of $161.6 million as of September 30, 2026, a decrease from $216.3 million at year-end 2025, primarily driven by a reduction in short-term investments. The company continues to incur losses and highlights risks related to its drone cell manufacturing, AI-based services, and the integration of UZ Energy.

Key figure
Net loss $13.4M
4:36 PM ET 10-Q
Financial Results Journey Medical Corp DERM

Journey Medical Q3 2026 Results: Net Loss of $1.31M, Loss Narrows

Journey Medical Corp reported a 16.7% increase in total revenue to $53.4 million for the nine months ended September 30, 2026, compared to the prior year. The company significantly reduced its net loss from $10.2 million to $3.9 million over the same period, driven by improved operating margins and lower research and development expenses.

Key figure
Net loss $1.31M
4:36 PM ET 10-Q
Financial Results Pono Capital Four, Inc. PONO

Pono Capital Four Q3 2026 Results: Net Income $507K

Pono Capital Four, Inc. reported a net income of $1,571,816 for the period from inception (January 2, 2026) through September 30, 2026, primarily driven by $2,346,853 in income earned on marketable securities held in the Trust Account. As a shell company, it maintains $122,346,853 in its Trust Account while reporting a shareholders' deficit of $2,654,584 due to the redemption value of Class A ordinary shares.

Key figure
Net income $507K
4:36 PM ET 8-K
Financial Results Gemini Space Station, Inc. GEMI

Gemini Space Station Financial Results

Gemini Space Station reported Q3 2026 total revenue of $40.9 million, a 19% year-over-year decline driven by a 73% drop in platform spot trading volume. Despite the revenue decline, the company improved its net loss by 63% year-over-year to $58.6 million through a 30% reduction in operating expenses and lower headcount.

Term
Q3 2026

“Operating expenses declined for a third consecutive quarter, and as we invest in growth, we intend to stay disciplined about where those dollars go. We’re clear-eyed about the work ahead and committed to getting it right: deepening our relationships with the customers who use Gemini, continuing to iterate, and investing where customers and markets are headed. We expect to be judged on results, and we intend to earn the confidence of our customers and shareholders one quarter at a time.”

Tyler Winklevoss, CEO of Gemini

“We started Gemini in 2014 because we believed crypto would change how people save, spend and move value, and we’re in this for the long term. Gemini 2.0 is our bet that the platforms that last will be the ones that own the regulated infrastructure underneath. We’re building ours to serve customers directly and to be something other platforms can build on.”

Cameron Winklevoss, President of Gemini
4:36 PM ET 10-Q
Financial Results enCore Energy Corp. EU

enCore Energy Q3 2026 Results: Net Loss of $33.9M, Loss Widens

enCore Energy Corp. is a non-accelerated filer and smaller reporting company focused on uranium exploration and extraction. As of November 9, 2026, the company had 195,668,102 common shares outstanding and reported a history of negative operating cash flows while pursuing an expansion-by-acquisition strategy.

Key figure
Net loss $33.9M
4:36 PM ET 10-Q
Financial Results Cibus, Inc. CBUS

Cibus Q3 2026 Results: Net Loss of $21.9M, Loss Narrows

Cibus, Inc. reported a net loss of $21.9 million for the third quarter of 2026, with revenue increasing to $0.8 million from $0.6 million in the prior year period. The company's cash position improved slightly to $10.7 million as of September 30, 2026, supported by $31.0 million in net cash provided by financing activities during the first nine months of the year.

Key figure
Net loss $21.9M
4:35 PM ET 10-Q
Financial Results Spero Therapeutics, Inc. SPRO

Spero Therapeutics Q3 2026 Results: Net Loss of $44.3M, Loss Widens

Spero Therapeutics reported that the FDA approved GSK’s NDA resubmission for Utebzi in June 2026, shifting the company's focus to the development of SP001. As of November 6, 2026, the company had 58,264,577 shares of common stock outstanding and continues to rely on milestone payments and royalties from its GSK partnership to fund operations.

Key figure
Net loss $44.3M
4:35 PM ET 8-K
Financial Results CapsoVision, Inc CV

CapsoVision Financial Results

CapsoVision reported Q3 2026 revenue of $3.6 million and a gross margin of 49%, while highlighting the recent FDA clearance and launch of its AI Highlights tool. The company also completed enrollment for its second-generation CapsoCam Colon study and raised approximately $19.5 million in net proceeds through a registered direct offering and ATM program during the quarter.

Term
Q3 2026

“The FDA clearance and subsequent U.S. launch of AI Highlights marks an important step forward for CapsoVision. Our four-camera, 360-degree panoramic capsule already provides physicians with a differentiated view of the small bowel. By combining that imaging capability with AI-assisted review, we believe we can reduce reading time, improve detection accuracy compared with manual review, and give physicians an additional level of diagnostic confidence.”

Johnny Wang, President and Chief Executive Officer

“At the same time, completing enrollment in our colon clinical study brings us closer to our planned FDA submission by year end, which we believe represents a substantially larger market opportunity. With the support of our existing shareholders through our recent financing, we are focused on translating these milestones into broader adoption and long-term growth.”

Johnny Wang, President and Chief Executive Officer
4:35 PM ET 8-K
Financial Results WhiteHawk Minerals Corp. WHK

WhiteHawk Minerals Financial Results

WhiteHawk Minerals Corp. reported Q3 2026 financial results including record production of 71.3 MMcfe/d and net income of $6.9 million. Concurrently, the company announced the $41.0 million acquisition of mineral and royalty interests in the Marcellus/Appalachian Basin from Three Rivers Royalty II, LLC. The company also declared a quarterly dividend of $0.50 per share.

Counterparty
Three Rivers Royalty II, LLC

“Continuing the momentum, WhiteHawk is benefiting from its base business and two-pronged acquisition strategy, driving an increase in Cash Available for Distribution and net asset value. We continue to benefit directly from our best-in-class operators’ performance and growth potential. We are particularly excited by EQT’s pending acquisition of Range, which brings together two of our largest Appalachia operators. We believe the combined company’s scale, inventory depth and low-cost structure are well aligned with WhiteHawk’s interests and further support the long-term development of our core mineral position. At the same time, our two-pronged acquisition strategy continues to deliver. Since our IPO, we have signed 22 acquisitions totaling $157.3 million, including 20 ground game transactions totaling over $11 million. We believe these transactions, and execution on our acquisition pipeline, will continue to drive meaningful value for shareholders in the short, medium and long term.”

Daniel Herz, Chairman, President and Chief Executive Officer
4:34 PM ET 10-Q
Financial Results Altimmune, Inc. ALT

Altimmune Q3 2026 Results: Net Loss of $31.6M, Loss Widens

Altimmune, Inc. reported a net loss of $77.0 million for the nine months ended September 30, 2026, compared to $60.7 million in the prior year, driven by increased research and development expenses. The company significantly strengthened its balance sheet through public and direct offerings, ending the period with $495.6 million in total assets, including $265.1 million in cash and investments.

Key figure
Net loss $31.6M
4:33 PM ET 6-K
Financial Results Standard Lithium Ltd. SLI

Standard Lithium Q3 2026 Results: Net Loss of $36.7M, Loss Widens

Standard Lithium Ltd. changed its functional currency from CAD to USD effective July 1, 2026, reflecting its advancing U.S. development projects. The company reported a carrying amount of $210.5 million for its equity method investment in the Smackover Lithium joint venture with Equinor as of September 30, 2026.

Key figure
Net loss $36.7M
4:33 PM ET 10-Q
Financial Results Net Power Inc. NPWR

Net Power Q3 2026 Results: Net Loss of $6.46M, Loss Narrows

Net Power Inc. is a non-accelerated filer and emerging growth company focused on power generation technology. The filing highlights significant risks including a pause in Texas data center permits, the need for additional capital, and the full impairment of its La Porte Demonstration Facility assets.

Key figure
Net loss $6.46M
4:33 PM ET 10-Q
Financial Results First Keystone Corp FKYS

First Keystone Q3 2026 Results: Net Income $3.74M, Up 33.2% YoY

First Keystone Corp reported a net income of $9.475 million for the nine months ended September 30, 2026, up from $6.775 million in the prior year period. Total assets grew significantly to $1.726 billion from $1.531 billion at year-end 2025, primarily driven by a $178 million increase in total deposits.

Key figure
Net income $3.74M · +33.2% YoY

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.